. . . . . . . . . "\"Nebivolol Tablets are contraindicated in the following conditions: * Severe bradycardia * Heart block greater than first degree * Patients with cardiogenic shock * Decompensated cardiac failure * Sick sinus syndrome (unless a permanent pacemaker is in place) * Patients with severe hepatic impairment (Child-Pugh >B) * Patients who are hypersensitive to any component of this product * Severe bradycardia (4) * Heart block greater than first degree (4) * Patients with cardiogenic shock (4) * Decompensated cardiac failure (4) * Sick sinus syndrome (unless a permanent pacemaker is in place) (4) * Patients with severe hepatic impairment (Child-Pugh >B) (4) * Hypersensitive to any component of this product (4)\"" . . . . . "RSA" . "MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCODwZkXojpEKwk7Ldj2oPPfCstvqrcpgCaTLo235K7ht9C7E1GCkLvUuL2b4VWXJTcZx/hxgDauR8hUeYq/lS6tfTL9yFZsnfl+PWYDyz7vv6N+wJVx2LL8bO6ntCjcOzvW2t2WUeF12Sb6b3I6uOYP0N8iQKts1WasY/yEYKAHQIDAQAB" . "FMtsyGe/0Q76OGNTIVlFrDFqPsDSIPLli+mQmwALJL5IlP45AFVJt0JPK3Rc6FuiEtEiRs0efqglxAzDnoeEwjKX7xv67eIklwpNK4ymEcUGFoXj28jB1HoSAI/V7U/Yl9z8I8i1cS81jVZaawfE8wShiQg9e3oOpg+TZJk9QKQ=" . . "2021-08-23T12:39:25.045+02:00"^^ . . . . .